Health Care & Life Sciences » Biotechnology | BBI Life Sciences Corp.

BBI Life Sciences Corp. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
140
245
418
329
261
215
Total Accounts Receivable
56
219
72
91
113
151
Inventories
59
58
62
66
77
87
Other Current Assets
8
22
25
25
34
16
Total Current Assets
264
543
576
511
484
468
Net Property, Plant & Equipment
147
146
186
311
515
615
Total Investments and Advances
26
-
-
13
32
30
Intangible Assets
1
4
10
15
16
14
Other Assets
41
56
45
34
36
33
Total Assets
479
749
816
884
1,084
1,161
ST Debt & Current Portion LT Debt
-
-
-
-
3
Accounts Payable
9
7
9
13
16
Income Tax Payable
-
-
5
-
-
Other Current Liabilities
77
117
126
155
231
Total Current Liabilities
86
124
140
168
250
Long-Term Debt
-
-
-
-
5
Deferred Taxes
5
5
6
6
4
Total Liabilities
90
129
146
174
260
Common Equity (Total)
370
618
669
704
825
Total Shareholders' Equity
370
618
669
704
825
Total Equity
386
618
669
709
824
Liabilities & Shareholders' Equity
479
749
816
884
1,084
Accumulated Minority Interest
-
-
17
5
1
Non-Equity Reserves
2
2
1
1
-

About BBI Life Sciences

View Profile
Address
No. 698, Xiangmin Road
Shanghai Shanghai 201611
China
Employees -
Website http://www.bbi-lifesciences.com
Updated 07/08/2019
BBI Life Sciences Corp. is an investment holding company that engages in the development, manufacture, and sale of various life sciences products used in scientific research. The firm also provides life sciences related services. It operates through the following segments: DNA Synthesis Products, Genetic Engineering Services, Life Sciences Research Consumables, and Protein and Antibody Related Products and Services.